Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Chiorazzi

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
The Journal of Clinical Investigation|November 23, 2021
B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemiaAndrea N Mazzarello, Eva Gentner-Göbel, Marcus Dühren-von Minden, et al.
The Journal of Clinical Investigation|February 16, 2005
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cellsBradley T Messmer, Davorka Messmer, Steven L Allen, et al.
Molecular Medicine (Cambridge, Mass.)|July 18, 2008
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18)Brian A McCarthy, Erin Boyle, Xue Ping Wang, et al.
Blood|August 20, 2009
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cellsTill Seiler, Manuela Woelfle, Sophia Yancopoulos, et al.
Haematologica|September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemiaClaudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
BMC Bioinformatics|November 21, 2018
Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemiaEleftheria Polychronidou, Ilias Kalamaras, Andreas Agathangelidis, et al.
Leukemia|January 28, 2021
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic targetFlorencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, et al.
Haematologica|November 8, 2011
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevancePreetesh Jain, Mohammad Javdan, Franziska K Feger, et al.
Molecular Medicine (Cambridge, Mass.)|November 15, 2008
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidationRosa Catera, Gregg J Silverman, Katerina Hatzi, et al.
Haematologica|February 20, 2025
Chronic lymphocytic leukemia often arises by a multiclonal selection processDavide Bagnara, Andrea N Mazzarello, Niccolò Cardente, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
The Journal of Clinical Investigation|November 23, 2021
B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemiaAndrea N Mazzarello, Eva Gentner-Göbel, Marcus Dühren-von Minden, et al.
The Journal of Clinical Investigation|February 16, 2005
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cellsBradley T Messmer, Davorka Messmer, Steven L Allen, et al.
Molecular Medicine (Cambridge, Mass.)|July 18, 2008
Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18)Brian A McCarthy, Erin Boyle, Xue Ping Wang, et al.
Blood|August 20, 2009
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cellsTill Seiler, Manuela Woelfle, Sophia Yancopoulos, et al.
Haematologica|September 11, 2025
IGLV3-21<sup>R110</sup>-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemiaClaudia Fischer, Shih-Shih Chen, Johanna Nimmerfroh, et al.
BMC Bioinformatics|November 21, 2018
Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemiaEleftheria Polychronidou, Ilias Kalamaras, Andreas Agathangelidis, et al.
Leukemia|January 28, 2021
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic targetFlorencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, et al.
Haematologica|November 8, 2011
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevancePreetesh Jain, Mohammad Javdan, Franziska K Feger, et al.
Molecular Medicine (Cambridge, Mass.)|November 15, 2008
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidationRosa Catera, Gregg J Silverman, Katerina Hatzi, et al.
Haematologica|February 20, 2025
Chronic lymphocytic leukemia often arises by a multiclonal selection processDavide Bagnara, Andrea N Mazzarello, Niccolò Cardente, et al.
Pageof 17